Morgan Stanley raises Pharvaris PT to $41 from $37, maintains Overweight rating.

jueves, 4 de diciembre de 2025, 8:18 am ET1 min de lectura
PHVS--

Morgan Stanley raises Pharvaris PT to $41 from $37, maintains Overweight rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios